Home  >  News
eppen_NEW-Himac_Jan_2026
you can get e-magazine links on WhatsApp. Click here
News
  Galderma provides update on arbitration case regarding neuromodulator research and development partnership,   January 23, 2026
  US FDA grants Orphan Drug Designation to BlueRock Therapeutics’ investigational cell therapy OpCT-001 to treat retinitis pigmentosa,   January 23, 2026
  G Square inks agreement to acquire majority stake in Finnish MedTech company, Serres to accelerate global growth and sustainability leadership,   January 21, 2026
  NMPA accepts Akeso’s supplemental New Drug Application for gumokimab to treat active ankylosing spondylitis,   January 21, 2026
  GSK, Pfizer and Shionogi agree on changes to ViiV Healthcare shareholding,   January 21, 2026
  Hemostemix receives US FDA support for its basket protocol approach,   January 20, 2026
  Daiichi Sankyo receives Prime Minister’s Award for Japan Medical Research and Development Grand Prize,   January 20, 2026
  GSK to acquire California-based biopharma company, RAPT Therapeutics for $2.2 billion,   January 20, 2026
  iRegene's NouvNeu001 receives US FDA Regenerative Medicine Advanced Therapy designation to treat Parkinson's disease,   January 20, 2026
  UK MHRA statement on new review of paracetamol safety during pregnancy,   January 20, 2026
  AbelZeta announces AstraZeneca agreed to acquire AbelZeta’s 50% share of China development and commercialization rights to C-CAR031,   January 20, 2026
  Harbour BioMed acquires common stock in Spruce Biosciences, deepening strategic collaboration,   January 20, 2026
  US FDA grants Orphan Drug Designation to Atossa Therapeutics’ (Z)-endoxifen to treat Duchenne muscular dystrophy,   January 19, 2026
  US FDA grants Breakthrough Therapy designation to Novartis’ ianalumab for Sjögren’s disease,   January 19, 2026
  European Commission approves Sobi’s Aspaveli for the treatment of C3G and primary IC-MPGN,   January 19, 2026
  Avalon Healthcare Solutions announces strategic investment to accelerate the future of diagnostic intelligence,   January 17, 2026
  UK MHRA approves up to 7.2mg dose of semaglutide for patients with obesity only,   January 17, 2026
  China NMPA approves Sanofi’s Myqorzo for obstructive hypertrophic cardiomyopathy and Redemplo for familial chylomicronemia syndrome,   January 17, 2026
  Zylox-Tonbridge to acquire Germany-based medical technology company, Optimed to accelerate expansion in the global medtech market,   January 17, 2026
  US FDA grants Orphan Drug Designation to Adolore BioTherapeutics’ Kv7-activating rdHSV-CA8 therapy to treat erythromelalgia,   January 16, 2026

  • Results Found: 22418
  • 1
    •  
  • 2
    •  
  • 3
    •  
  • 4
    •  
  • 5
    •  
  • Go to
  • Total Number of Pages: 1121
 Back
 
ASIA_PHARMA_EXPO_2026
Ana_Lab_India_2026
PharmaCore_India_2026
Copyright © 2024 Saffron Media Pvt. Ltd | twitter
 
linkedin
 
 
linkedin
 
instagram